Pfizer to buy Seagen for about $43 billion
Pfizer Inc said on Monday it would buy Seagen Inc for about $43 billion to expand its portfolio of cancer treatments.
Pfizer will pay $229 in cash per Seagen share, a 32.7% premium to Friday's closing price.
Shares of Seagen were up 23% before the bell.
Seagen expects to generate about $2.2 billion of revenue in 2023.
Follow Emirates 24|7 on Google News.